BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270216
DTEND;VALUE=DATE:20270219
DTSTAMP:20260906T232246
CREATED:20260903T113207Z
LAST-MODIFIED:20260903T113207Z
UID:10002373-1802736000-1802995199@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Rethinking Neurodegeneration
DESCRIPTION:This conference focuses on new perspectives on neurodegeneration and dementia\, including the question of whether diseases such as Alzheimer’s may represent interconnected pathological processes rather than clearly distinct disorders. Researchers from across the field will meet in Hanover to discuss current research. \nNeurodegenerative diseases and dementia are a dramatic burden for our aging societies. While the age-associated demise of neurons leading to dementia has been intensively studied for decades\, the individual causes of degeneration are not fully understood. Consequently\, causative therapies or a cure are still missing. \n\n\nAlthough dementia-associated diseases such as Alzheimer’s disease and Frontotemporal Dementia exhibit substantial heterogeneity at multiple levels – including genetics and affected brain regions – an increasing number of shared mechanistic pathways are being identified. These findings raise the possibility that “dementia” may represent a continuum of pathological processes rather than a collection of distinct disease entities. For instance\, most Alzheimer’s disease cases are currently described as mixed pathologies\, as they involve the deposition of several proteins that are found in various types of neurodegenerative disorders; examples are the deposition of amyloid beta\, tau\, alpha-synuclein\, or TDP-43. \nThe Herrenhausen Conference “Rethinking Neurodegeneration – Challenging established paradigms and exploring new paths” aims to address these complexities from a broad and interdisciplinary perspective. It will provide an unbiased perspective on neurodegeneration\, the multifactorial risk factors\, and aging from the standpoint of molecular and cellular biology as well as human genetics\, epidemiology\, and clinical research. It will bring together experts in neurodegeneration\, dementia and aging research to present their perspectives\, creating a unique opportunity for new and unprecedented synergies. Moreover\, this conference aims to move beyond the beaten paths encouraging broader perspectives and outside-the-box thinking\, potentially driving a paradigm shift. Given that neurodegeneration and dementia are multifactorial and age-associated conditions\, they need to be explored accordingly. \nThe conference also includes contributions from early career researchers and encourages young scientists to broaden their perspectives on long-standing medical challenges. \nIn many ways\, “Rethinking Neurodegeneration – Challenging established paradigms and exploring new paths” reflects the spirit of the famous quote attributed to Max Planck: “When you change the way you look at things\, the things you look at change”. \n\n\n\n\n\nTravel grants for early career researchers\nWe award up to 10 travel grants to PhD-/MD-students and postdoctoral researchers. The grants are intended to support early career researchers whose work relates to the scientific themes of the conference and who wish to actively contribute to the interdisciplinary exchange on neurodegeneration and dementia research. Applications will be evaluated based on scientific quality\, originality\, relevance to the conference topics\, and the potential contribution to interdisciplinary discussion. \n\nThe deadline for applications is September 30\, 2026. All applicants will be informed of the outcome of their application mid October 2026. \nFor details\, please see the document Call HK Neurodegeneration Travel Grants (PDF) \n\nTravel Grants Application \n\nConfirmed Speakers\n\nYou can find all confirmed speakers in the downloadable document. \n\nConfirmed Speakers \n\nRegistration\n\nThere is no attendance fee\, but prior registration is mandatory. \nRegistration will open at the end of July 2026. The number of participants is strictly limited and attendance is subject to selection by the organisers. The registration deadline is November 1\, 2026. Your attendance will be confirmed by mid November 2026. \n\nRegistration link for participants
URL:https://www.dementiaresearcher.nihr.ac.uk/event/rethinking-neurodegeneration/
LOCATION:Tagungszentrum Schloss Herrenhausen\, Hannover\, Herrenhäuser Str. 5\, Hanover\, 30419\, Germany
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/09/VolkswagenStiftung-Logo.png
GEO:52.3911158;9.6977151
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Tagungszentrum Schloss Herrenhausen Hannover Herrenhäuser Str. 5 Hanover 30419 Germany;X-APPLE-RADIUS=500;X-TITLE=Herrenhäuser Str. 5:geo:9.6977151,52.3911158
END:VEVENT
END:VCALENDAR